This information was published on 2024-06-28T13:51:28 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2447782 |
| (220) |
03 May 2024
|
| (300) |
US, 06 Nov 2023, 98257358
|
| (511) (510) |
Class 5
Pharmaceutical and biological preparations for medical use; Pharmaceutical and biological preparations for use in oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; Therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes. |
| (540) | UMDARZI |
| (550) | Word |
| (730) |
IDEAYA BIOSCIENCES, INC.
|
| (750) |
AJ Park
|
Find out more about publications on the About page.